Article Per Year (5 Year)
p-Index From 2021 - 2026
4.328
P-Index
This Author published in this journals
All Journal HAYATI Journal of Biosciences Farmaka Dharmakarya : Jurnal Aplikasi Ipteks Untuk Masyarakat Indonesian Journal of Pharmaceutical Science and Technology Jurnal Farmasi Klinik Indonesia Pharmauho: Jurnal Farmasi, Sains, dan Kesehatan The Indonesian Biomedical Journal Medical Laboratory Technology Journal Molecular and Cellular Biomedical Sciences (MCBS) Majalah Farmasi dan Farmakologi (Trends in Pharmacy and Pharmaceutical Sciences) JMM (Jurnal Masyarakat Mandiri) Jurnal Kreativitas PKM FITOFARMAKA: Jurnal Ilmiah Farmasi Current Research on Biosciences and Biotechnology Indonesian Journal of Biological Pharmacy Medical Sains : Jurnal Ilmiah Kefarmasian Jurnal Kesehatan Sciences of Pharmacy Public Health Risk Assesment Journal Medical Sains : Jurnal Ilmiah Kefarmasian
Melisa Intan Barliana
Fakultas Farmasi Universitas Padjadjaran
Agriculture, Biological Sciences & Forestry Arts Humanities Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Computer Science & IT Dentistry Earth & Planetary Sciences Economics, Econometrics & Finance Engineering Health Professions Immunology & microbiology Languange, Linguistic, Communication & Media Materials Science & Nanotechnology Medicine & Pharmacology Neuroscience Nursing Public Health Veterinary Other

Published : 42 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 42 Documents
Search

 1   2   3   4   5 
Skrining Fitokimia dan Profil KLT Ekstrak dan Fraksi Daun Manggu Leuweung (Garcinia celebica L.) Peratiwi, Shafira Galuh; Tahara, Nabila; Mustikawati, Bunga; Maisyarah, Intan Timur; Indradi, Raden Bayu; Barliana, Melisa Intan
Indonesian Journal of Biological Pharmacy Vol 3, No 1 (2023): IJBP (April)
Publisher : Department of Biological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/ijbp.v3i1.44481

Abstract

Tanaman manggu leuweung (Garcinia celebica L.) merupakan tanaman yang termasuk genus Garcinia danfamili Clusiaceae. Genus Garcinia spp. telah banyak diteliti karena memiliki potensi untuk dikembangkansebagai alternatif pengobatan namun belum banyak penelitian yang dilakukan pada ekstrak danfraksi daun G. celebica. Dilaporkan ekstrak dari daun G. celebica memiliki aktivitas sebagai antioksidan,antimikroba, antikanker dan antiplasmodial. Tujuan dari penulisan ini untuk mengetahui kandungansenyawa metabolit sekunder dan profil KLT yang pada ekstrak etanol, fraksi n-heksan dan fraksi etilasetat daun G. celebica. Penelitian dilakukan melalui tahap ekstraksi dengan metode maserasi, fraksinasisecara Ekstraksi Cair-Cair (ECC), pemeriksaan ekstrak dan fraksi dengan Kromatografi Lapis Tipis(KLT) dan skrining fitokimia. Berdasarkan hasil skrining fitokimia ekstrak daun G. celebica mengandungsenyawa flavonoid, saponin, polifenol, monoterpen/seskuiterpen. Fraksi n-Heksana daun G. celebicamengandung senyawa flavonoid, polifenol dan monoterpen/seskuiterpen sedangkan fraksi etil asetatdaun G. celebica L. mengandung senyawa flavonoid, saponin, polifenol, monoterpen/seskuiterpen.
Phytochemical Profile Extracts and Fractions of Pisitan Monyet (Dysoxylum caulostachyum Miq.) Bonor, Toga; Among, Sayyid; Febriyanti, Raden Maya; Maisyarah, Intan Timur; Barliana, Melisa Intan
Indonesian Journal of Biological Pharmacy Vol 4, No 1 (2024): IJBP (April)
Publisher : Department of Biological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/ijbp.v4i1.55097

Abstract

Dysoxylum is a genus from the Meliaceae family which has 905 species. One species of this genus is Dysoxylum caulostachyum Miq. This species is a plant that has long been consumed as daily food for primates. This plant is starting to be widely researched for its potential for treatment. There are several previous studies showing that D. caulostachyum has antiproliferative, antiplasmodial and anticancer bioactivity. The aim of this paper is to determine the phytochemical profile of D. caulostachyum leaves in the ethanol extract, n-hexane fraction and ethyl acetate fraction of D. caulostachyum leaves. The research was carried out through extraction stages using the maceration method, fractionation using Liquid-Liquid Extraction (ECC), examination of extracts and fractions using Thin Layer Chromatography (TLC), phytochemical screening, and measurement of total phenolic and total flavonoid levels. Based on phytochemical screening, D. caulostachyum leaf extract contains flavonoids, saponins, polyphenols, monoterpenes/sesquiterpenes, quinones, and triterpenes/steroids. The n-Hexane fraction of D. caulostachyum leaves contains quinone compounds, the ethyl acetate fraction of D. caulostachyum leaves contains flavonoids, quinones and polyphenol compounds, while the water fraction of D. caulostachyum contains polyphenol and quinone compounds. From the extract and leaf fractions of D. caulostachyum, data was obtained that the extract contained the highest levels of total phenolics and flavonoids, namely 92.361 ± 1.7245 mg GAE/g and 92.361 ± 1.7245, respectively.
EDUKASI KESEHATAN JIWA PADA IBU-IBU DI POSYANDU DESA KUTAMANDIRI KECAMATAN TANJUNGSARI KABUPATEN SUMEDANG Rendrayani, Farida; Zakiyah, Neily; Barliana, Melisa Intan; Puspitasari, Irma Melyani
DHARMAKARYA: Jurnal Aplikasi Ipteks untuk Masyarakat Vol 13, No 1 (2024): Maret, 2024
Publisher : Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/dharmakarya.v13i1.42700

Abstract

Kesehatan jiwa merupakan hak asasi manusia, yang tidak terpisahkan dari kesehatan dan kesejahteraan secara umum. Literasi mengenai kesehatan jiwa pada masyarakat khususnya depresi pada kaum ibu, memegang peranan penting dalam pencegahan dampak merugikan baik pada skala lokal maupun global. Kegiatan pengabdian kepada masyarakat (PPM) ini dilakukan untuk meningkatkan literasi mengenai depresi pada kelompok kritikal yaitu, ibu-ibu yang memiliki anak balita. Kegiatan ini dilakukan dengan memberikan edukasi kesehatan jiwa dan membagikan flyer kepada ibu-ibu di Posyandu Kendedes Desa Kutamandiri, Kecamatan Tanjungsari Kabupaten Sumedang. Efektivitas kegiatan dalam meningkatkan literasi kesehatan jiwa pada ibu-ibu tersebut kemudian diukur berdasarkan perubahan skor tes pada saat sebelum dan sesudah penyuluhan menggunakan analisis statistik Wilcoxon-signed rank. Hasil pretest menunjukkan bahwa 68,75% peserta memiliki tingkat pengetahuan yang baik, yang diinterpretasikan berdasarkan nilai skor ≥ median (median = 7, rentang skor 3 – 8). Pada saat post-test terdapat peningkatan nilai skor dengan rata-rata nilai menjadi 8,19; rentang skor menjadi 6 -10. Hasil uji Wilcoxon-signed rank menunjukkan bahwa terdapat perbedaan yang signifikan pada skor pre-test dan post-test (p = 0,03). Kegiatan PPM berupa edukasi kesehatan jiwa terbukti efektif dalam meningkatkan pengetahuan mengenai depresi pada ibu-ibu. Kegiatan edukasi merupakan langkah penting dalam mencapai kesehatan jiwa yang lebih baik di masyarakat. Dengan demikian, kegiatan PPM ini harus terus berlanjut, baik dengan kelompok target yang sama maupun berkembang pada kelompok kritikal lainnya.
EFIKASI, KEAMANAN, EFISIENSI BIAYA PENGGUNAAN REJIMEN BEDAQUILIN, PRETOMANID, DAN LINEZOLID (BPaL) DALAM PENGOBATAN TUBERKULOSIS RESISTEN OBAT GANDA Pradipta, Ivan; Melisa Intan Barliana; Dedi Suyatno; Widya Naftalia Wijasa
Majalah Farmasi dan Farmakologi Vol. 27 No. 3 (2023): MFF
Publisher : Faculty of Pharmacy, Hasanuddin University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20956/mff.v27i3.31781

Abstract

Kejadian tuberkulosis resisten obat ganda (TB-ROG) merupakan salah satu faktor utama kegagalan dalam penanganan tuberkulosis (TB). Pada tahun 2020 terdapat pedoman baru pengobatan TB-ROG yang menggunakan rejimen bedaquilin, pretomanid, dan linezolid (BPaL). Rejimen tersebut memiliki komposisi obat yang lebih sederhana dan lebih singkat. Namun, informasi mengenai efikasi, keamanan dan efisiensi biaya belum banyak tersosialisasikan secara luas. Tujuan dari review naratif ini adalah untuk mendeskripsikan efikasi, keamanan, dan efisiensi biaya pemberian rejimen BPaL pada pengobatan TB-ROG yang dapat bermanfaat untuk strategi pengobatan pada pasien TB-ROG. Studi review naratif ini dilakukan dengan mengacu pada berbagai referensi yang terfokus pada penggunaan rejimen BPaL. Mesin pencarian yang digunakan dalam pencarian literatur antara lain pubmed dan google scholar pada periode 2018-2023. Berdasarkan penelusuran, diperoleh 5 artikel yang disertakan dalam tinjauan naratif ini. Penggunaan rejimen BPaL dengan atau tanpa variasi dosis dan lama pemberian obat linezolid pada pengobatan TB-ROG, memiliki keberhasilan pengobatannya yang tinggi dengan efektifitas sebesar 84 – 93 %. Reaksi obat yang tidak dikehendaki telah dilaporkan setelah penggunaan rejimen BPaL. Beberapa diantaranya terkait dengan penggunaan linezolid, yaitu kajadian neuropati perifer, myelosupresi, neuritis optik, dan lainnya terkait dengan penggunaan bedaquilin dan pretomanid, yaitu kejadian perpanjangan interval QT jantung dan hepatotoksisitas. Studi mengenai efisiensi biaya pengobatan menunjukan penggunaan rejimen BPaL hasilnya jauh lebih murah 57% dibandingkan dengan rejimen konvensional. Studi ini menyimpulkan bahwa rejimen BPaL memberikan keberhasilan pengobatan selama 26 minggu dengan beberapa kejadian ROTD yang perlu diperhatikan. Selain itu, rejimen BPaL dapat menekan pembiayaan pengobatan langsung dibandingkan rejimen konvensional.
Potency of Peripheral Blood- and Umbilical Cord Blood-derived Dendritic Cells and Their Secretomes as Vaccines for Cancer Haifa, Rima; Sartika, Cynthia Retna; Faried, Ahmad; Hadisaputri, Yuni Elsa; Chouw, Angliana; Wijaya, Andi; Barliana, Melisa Intan
Molecular and Cellular Biomedical Sciences Vol 8, No 1 (2024)
Publisher : Cell and BioPharmaceutical Institute

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21705/mcbs.v8i1.358

Abstract

Dendritic cell (DC) vaccines, as immunotherapy agents, can gather up and transport cancer-related antigens to T lymphocytes, activating anti-tumor effector responses. After being activated by DC, cytotoxic T lymphocyte cells (CTL) will secrete the cytolytic granzyme B that can effectively induce rapid apoptosis of target cells. On the other hand, DC also secrete several cytokines and a large number of exosomes, which together operate as a whole antigen-presenting entity. The efficacy of the vaccine’s treatment may be affected by the sources used for DC vaccines. Umbilical cord blood (UCB) from healthy donors can be employed when autologous cancer patient’s peripheral blood (PB) cannot be used as a source for isolating DC due to genetic abnormalities. Comparing UCB to other sources, there is a painless method of collecting sources as opposed to PB, which necessitates a venipuncture or leukapheresis procedure to isolate the blood. Many studies related to the use of PB-DC have been carried out, but research on potential comparisons between PB-DC and UCB-DC is still very limited. In this review, the potential of PB- and UCB-derived DC and their secretomes for cancer will be discussed.Keywords: dendritic cells, vaccines, umbilical cord blood, peripheral blood
ERCC2 rs13181 and ERCC1 rs11615 polymorphisms in non-small cell lung cancer patients in West Java: towards personalized medicine approaches Afifah, Nadiya Nurul; Effendi, M. Fariz; Diantini, Ajeng; Barliana, Melisa Intan; Intania, Ruri
Current Research on Biosciences and Biotechnology Vol. 6 No. 2 (2025)
Publisher : Institut Teknologi Bandung

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.5614/crbb.2025.6.2/3DCBQ451

Abstract

Non-Small Cell Lung Cancer (NSCLC) is a disease with a high incidence rate, low survival due to late diagnosis and treatment delays, and varying effectiveness of platinum-based chemotherapy. Individual responses to platinum-based chemotherapy are influenced by genetic polymorphisms in genes affecting pharmacokinetic and pharmacodynamic mechanisms. This study focuses on identifying polymorphisms in the ERCC2 and ERCC1 genes, which play a role in platinum pharmacodynamics, and their effects on chemotherapy response. The study involved 23 NSCLC patients conducted at Dr. H.A. Rotinsulu Lung Hospital in Bandung. Polymorphism data were obtained through genotype analysis using sequencing methods from prospective whole blood samples of patients, while chemotherapy effectiveness was assessed by evaluating chemotherapy response using the RECIST 1.1 method, and radiological response prediction and prognostic factors were determined through CYFRA 21-1 levels. The results showed an OR of 0.964 (95% CI: 0.160 - 5.795) for ERCC2 rs13181 CC + AC vs. AA against chemotherapy response evaluation by RECIST 1.1, and 0.722 (95% CI: 0.062 - 8.464) against CYFRA 21-1 values. Meanwhile, for ERCC1 rs11615, an OR of 0.268 (95% CI: 0.046 - 1.548) CT + TT vs. CC for RECIST 1.1 and 0.3 (95% CI: 0.026 - 3.427) for CYFRA 21-1 values were obtained. In clinical interpretation, it is known that variant alleles at rs13181 and rs11615 have potential for better chemotherapy response although not statistically significant (p>0.05), these results can be considered when assessing patient response to chemotherapy within six cycles. This study provides initial data and forms the basis for future comprehensive cohort observational research.
Characterization of Lactococcus garvieae Isolated from Wadi Papuyu (Anabas testudineus Bloch) Fermentation of Indonesian Origin as a Probiotic Candidate Soemarie, Yulistia Budianti; Pratama, Rizki Rahmadi; Milanda, Tiana; Barliana, Melisa Intan
Sciences of Pharmacy Volume 4 Issue 2
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar0402317

Abstract

Lactococcus garvieae was isolated from the traditional fermented food Wadi Papuyu (Anabas testudineus Bloch) and characterized for its potential as a probiotic candidate. Growth assays demonstrated that L. garvieae could proliferate in MRS medium, reaching cell counts exceeding 107 CFU/mL after 72 h of anaerobic incubation. The isolate exhibited optimal growth at both 30 °C and 37 °C, as indicated by significant increases in absorbance at these temperatures. However, in the bile salt tolerance test using 0.5% (w/v) bile salts, L. garvieae showed a marked decline in growth, with absorbance values decreasing substantially after 24 and 48 h, indicating insufficient bile tolerance. The autoaggregation assay revealed values below 10%, suggesting limited autoaggregation capability and reduced potential for colonization in the gastrointestinal tract. In contrast, the co-aggregation assay showed that L. garvieae was able to coaggregate with pathogenic bacteria such as Escherichia coli, Salmonella spp., and Shigella spp., with co-aggregation percentages exceeding 40% after 5 h. Antimicrobial activity tests demonstrated that L. garvieae produced strong inhibition zones (diameters >10–20 mm and >20 mm) against Gram-positive and Gram-negative pathogenic bacteria. These findings indicate that while L. garvieae exhibits promising antimicrobial activity and co-aggregation ability, its limited bile salt tolerance and autoaggregation capacity are significant constraints in its development as a probiotic candidate.
Optimizing diabetic retinopathy therapy with precision medicine: Can we do that in Indonesia? Putri, Nazwa Septiriana; Barliana, Melisa Intan
Public Health Risk Assesment Journal Vol. 3 No. 1: July (2025)
Publisher : Institute for Advanced Science, Social, and Sustainable Future

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61511/phraj.v3i1.2025.1840

Abstract

Background: Diabetes is one of the most common diseases in the world, including in Indonesia. High blood sugar levels in diabetics can cause various complications, one of which is diabetic retinopathy. The treatment used in diabetic retinopathy does not fully provide the desired therapeutic effect in all patients. Therefore, a study was conducted on the prescription drug approach to optimize diabetic retinopathy therapy. Methods: This narrative review was conducted by searching articles that discuss three main focuses, including (1) why precision medicine (PM) can be implemented in diabetic retinopathy (DR); (2) the application, benefits, and components of PM for DR; and (3) challenges in its implementation in Indonesia. The included articles are articles published in national and international journals between 2014 and 2025. Findings: This study reveals that diabetic retinopathy is a complication of diabetes whose development can be influenced by genetic and environmental factors of the patient. Precision medicine can be applied in determining the best therapy for diabetic retinopathy by analyzing the clinical condition history, molecular and biochemical biomarkers of patients using artificial intelligence or machine learning. Conclusion: optimization of diabetic retinopathy therapy can be done with a precision medicine approach by analyzing genetic factors and patient environmental factors. However, there are still some challenges in its application in Indonesia including health service disparities, regulatory issues, technology, costs, and human resources. To develop precision medicine in Indonesia, Indonesia should develop equitable distribution in health services, conduct policy and research more on DM and PM, and collaborate with other countries. This narrative review has several limitations: literature search was limited to 3 database sources, we did not assess the quality of the articles, and implementation steps and solutions for PM implementation in Indonesia are only discussed in general, not specifically for DR. Future research can be carried out by discussing in more depth the specific steps of PM implementation for DR. Novelty/Originality of this article: Although personalized medicine has been in the spotlight in the global. Novelty/Originality of this article: Although personalized medicine has been in the spotlight in the global medical world, its specific application in the treatment of diabetic retinopathy in a country with limited resources and diverse demographics such as Indonesia is still not widely explored. The originality lies in adapting precision medicine as a high-tech solution for diabetic retinopathy, which is one of the public health challenges.
Analisis Efektivitas Biaya Penggunaan Antipsikotik Tipikal (Haloperidol) dan Atipikal (Risperidon) pada Pasien Skizofrenia di RSUP Dr. Hasan Sadikin Bandung Syahrina, Nadira Alvi; Barliana, Melisa Intan; Zakiyah, Neily; Iskandar, Shelly
Indonesian Journal of Clinical Pharmacy Vol 13, No 2 (2024)
Publisher : Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.15416/ijcp.2024.13.2.61455

Abstract

Skizofrenia merupakan gangguan mental kronis yang membutuhkan terapi jangka panjang serta melibatkan biaya perawatan kesehatan yang besar. Penelitian ini bertujuan untuk menganalisis efektivitas biaya antara penggunaan risperidon dibandingkan dengan haloperidol pada terapi skizofrenia, serta menganalisis faktor utama yang memengaruhi nilai efektivitas biaya pada rawat inap di RSUP Dr. Hasan Sadikin Bandung (RSHS) pada 2017–2018. Data dikumpulkan secara retrospektif dari perspektif penyedia layanan kesehatan, mencakup total biaya medis langsung baik yang ditanggung rumah sakit maupun oleh Badan Penyelenggara Jaminan Sosial (BPJS). Nilai efektivitas diukur dalam penurunan penurunan skor PANSS. Hasil menunjukkan bahwa nilai average cost-effectiveness ratio (ACER) risperidon adalah Rp527.002 per satuan penurunan PANSS, sedangkan haloperidol Rp357.374. Berdasarkan perhitungan incremental cost-effectiveness ratio (ICER), haloperidol menunjukkan nilai Rp486.809 per satuan penurunan PANSS dibandingkan risperidon. Meskipun ICER haloperidol lebih tinggi dari risperidon, hasil tersebut masih berada dalam ambang batas willingness to pay yang ditetapkan di Indonesia (berdasarkan 1–3 kali PDB per kapita), sehingga terapi haloperidol dapat dikategorikan sebagai cost-effective. Dari sisi efisiensi biaya, haloperidol menghasilkan penghematan sekitar Rp378.737 dibandingkan risperidon. Dengan demikian, terapi haloperidol lebih dominan secara ekonomi dan layak dipertimbangkan sebagai pilihan pengobatan yang lebih efisien bagi pasien skizofrenia rawat inap di RSHS Bandung.
ABCB1 rs1045642 Genotypes and Clinical Response in Indonesian Patients with Systemic Lupus Erythematosus Pratama, Muhammad Syawal; Afifah, Nadya Nurul; Permatasari, Lany Indah; Kennardi, Gabriel Bagus; Hamijoyo, Laniyati; Sahiratmadja, Edhyana; Barliana, Melisa Intan
Indonesian Journal of Clinical Pharmacy Vol 13, No 3 (2024)
Publisher : Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.15416/ijcp.2024.13.3.62273

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease often managed with immunosuppressants such as methylprednisolone (MP) and azathioprine (AZA), although therapeutic responses vary among individuals. Genetic variation, including polymorphisms in the ATP-Binding Cassette Subfamily B Member 1 (ABCB1) gene encoding the P-glycoprotein drug transporter, may influence treatment outcomes. The rs1045642 polymorphism has been linked to variable responses in SLE, but data in Indonesian populations are scarce. This study aimed to describe the distribution of the ABCB1 rs1045642 polymorphism in SLE patients from Bandung, Indonesia, and to explore its potential association with therapy outcomes using MP and/or AZA. We conducted a cross-sectional study of 84 SLE patients, collecting clinical data from medical records. Treatment outcome was defined as achievement of lupus low disease activity state (LLDAS). Genomic DNA was extracted and sequenced to determine rs1045642 genotypes. A total of 84 SLE patients were included, predominantly aged 26–35 years (34%). Almost half had a disease duration of 6–10 years (49%). The majority achieved LLDAS (69%), and all patients were receiving methylprednisolone, with 78.6% also receiving azathioprine. The genotype distribution of ABCB1 rs1045642 was AA 10.71%, AG 61.91%, and TT 27.38%, which deviated from Hardy–Weinberg equilibrium (p < 0.05). However, genetic variations were observed among patients with SLE. Further studies on other possible polymorphisms related to the outcome of SLE therapy are needed.
Co-Authors Abdurahman Ridho Afifah, Nadya Nurul AGATHA VIKA PURWANINGTYAS Ahmad Faried Ahmad Muhtadi Ajeng Diantini, Ajeng Aliya Nur Hasanah Among, Sayyid Andi Wijaya ANDI WIJAYA Andi Wijaya Angliana Chouw, Angliana Anna Meiliana Anna Meiliana ARNANDA, QUINZHEILLA PUTRI Balqist, Syara Nur Fitri Bonor, Toga Chandra Agung Purnama Cissy Bana Kartasasmita Cynthia Retna Sartika, Cynthia Retna Dedi Suyatno Dewi Muliaty Didi Susanto Driyanti Rahayu Edhyana Sahiratmadja Effendi, M. Fariz ELLENA MAGGYVIN Erizal Sugiono Eva Feriadi Fajar, Desi Reski Febio Gutama Febriyanti, Maya Haifa, Rima HISBAN HAMID ARIFKI Ida Paulina Sormin Imas Maesaroh Indradi, Raden Bayu Intania, Ruri Irma Melyani Puspitasari Irma Rahayu Latarissa Irmansyah Irmansyah Ivan Pradipta Ivan Surya Pradipta Karina Erlianti Kennardi, Gabriel Bagus Keri Lestari Khaira, Syifa Komang Suma Triyasa Laniyati Hamijoyo, Laniyati LILY CYNTIA FAUZI Luki Yogaswara Yusuf Made Putra Semadhi Maisyarah, Intan Timur Maya Febriyanti Miftakh Nur Rahman Miswar Fattah Moses Prasetio Muhaimin Muhaimin Muhammad Fauzi Munir Alinu Mulki Mustikawati, Bunga Nadiya Nurul Afifah Nuning Nurcayani Peratiwi, Shafira Galuh Permatasari, Lany Indah Pratama, Muhammad Syawal Prayudi Santoso Putri Maharani Putri, Nazwa Septiriana Qolbina, Shofura Marsa Raden Maya Febriyanti Rendrayani, Farida Rimadani Pratiwi Rizki Rahmadi Pratama Rizky Abdulah Sahila, Elma N. M. R. Sartika Aprianti Shelly Iskandar Soemarie, Yulistia Budianti Syahrina, Nadira Alvi Tahara, Nabila Theresia Ratnadevi TIANA MILANDA Tina Rostinawati Widya Naftalia Wijasa Yudisia Ausi Yulistia Budianti Soemarie Yulistia Budianti Soemarie Yuni Elsa Hadisaputri Zakiyah, Neily Zelika Mega Ramadhania